Insufficient scRNA-seq data for expression of PLA2G2C at single-cell level.
Insufficient scRNA-seq data for expression of PLA2G2C at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 88% | 37.93 | 216 / 245 | 31% | 0.69 | 157 / 502 |
| esophagus | 89% | 46.79 | 1293 / 1445 | 3% | 0.05 | 5 / 183 |
| intestine | 86% | 159.22 | 830 / 966 | 5% | 0.09 | 27 / 527 |
| thymus | 4% | 0.39 | 29 / 653 | 76% | 1.86 | 460 / 605 |
| bladder | 52% | 10.62 | 11 / 21 | 15% | 0.34 | 74 / 504 |
| breast | 24% | 3.03 | 112 / 459 | 40% | 1.19 | 451 / 1118 |
| brain | 49% | 6.75 | 1304 / 2642 | 13% | 0.44 | 95 / 705 |
| uterus | 45% | 8.23 | 76 / 170 | 14% | 0.33 | 62 / 459 |
| stomach | 44% | 43.92 | 157 / 359 | 8% | 0.15 | 22 / 286 |
| lymph node | 0% | 0 | 0 / 0 | 45% | 0.84 | 13 / 29 |
| lung | 17% | 1.84 | 99 / 578 | 24% | 0.54 | 273 / 1155 |
| adrenal gland | 16% | 1.62 | 42 / 258 | 22% | 0.48 | 50 / 230 |
| ovary | 5% | 0.57 | 9 / 180 | 27% | 0.59 | 117 / 430 |
| liver | 28% | 4.16 | 63 / 226 | 4% | 0.06 | 15 / 406 |
| peripheral blood | 28% | 5.22 | 262 / 929 | 0% | 0 | 0 / 0 |
| kidney | 18% | 1.71 | 16 / 89 | 10% | 0.18 | 92 / 901 |
| skin | 8% | 0.92 | 144 / 1809 | 14% | 0.30 | 68 / 472 |
| spleen | 16% | 1.73 | 39 / 241 | 0% | 0 | 0 / 0 |
| pancreas | 0% | 0 | 0 / 328 | 13% | 0.32 | 24 / 178 |
| adipose | 12% | 1.24 | 141 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 11% | 0.14 | 9 / 80 |
| heart | 6% | 0.61 | 52 / 861 | 0% | 0 | 0 / 0 |
| blood vessel | 3% | 0.27 | 34 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 0% | 0.04 | 4 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006644 | Biological process | phospholipid metabolic process |
| GO_0006633 | Biological process | fatty acid biosynthetic process |
| GO_0048146 | Biological process | positive regulation of fibroblast proliferation |
| GO_0046470 | Biological process | phosphatidylcholine metabolic process |
| GO_0016042 | Biological process | lipid catabolic process |
| GO_0050482 | Biological process | arachidonic acid secretion |
| GO_0005576 | Cellular component | extracellular region |
| GO_0005509 | Molecular function | calcium ion binding |
| GO_0047498 | Molecular function | calcium-dependent phospholipase A2 activity |
| GO_0005102 | Molecular function | signaling receptor binding |
| GO_0005543 | Molecular function | phospholipid binding |
| Gene name | PLA2G2C |
| Protein name | Phospholipase A2 (EC 3.1.1.4) Putative inactive group IIC secretory phospholipase A2 (Phosphatidylcholine 2-acylhydrolase-like protein GIIC) |
| Synonyms | |
| Description | FUNCTION: Inactive phospholipase. . |
| Accessions | ENST00000247992.5 ENST00000429261.2 ENST00000679259.1 Q5R387 J3KMZ3 |